Financhill
Sell
49

INSM Quote, Financials, Valuation and Earnings

Last price:
$177.48
Seasonality move :
7.61%
Day range:
$175.00 - $178.10
52-week range:
$60.40 - $212.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
75.50x
P/B ratio:
40.02x
Volume:
747.3K
Avg. volume:
3.7M
1-year change:
151.55%
Market cap:
$37.8B
Revenue:
$363.7M
EPS (TTM):
-$6.18

Earnings Data

Next earnings date for INSM
Feb 19
2026
Most recent earnings per share
-$1.75
Missed by $0.38
(Oct 30/2025)
Consensus Estimate
-$1.37
(Oct 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

INSM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/19/2026 Q4 $174.3M -- -- -$1.36 --
10/30/2025 Q3 $115.5M $142.3M -$1.75 -$1.37 -$0.38
08/07/2025 Q2 $104.3M $107.4M -$1.70 -$1.31 -$0.39
05/08/2025 Q1 $91.2M $92.8M -$1.42 -$1.36 -$0.06
02/20/2025 Q4 $102.4M $104.4M -$1.32 -$1.16 -$0.15
10/31/2024 Q3 $93.2M $93.4M -$1.27 -$1.25 -$0.02
08/08/2024 Q2 $87.8M $90.3M -$1.94 -$1.23 -$0.72
05/09/2024 Q1 $78.8M $75.5M -$1.06 -$1.20 $0.14
02/22/2024 Q4 $82.6M $83.7M -$1.28 -$1.13 -$0.15
10/26/2023 Q3 $79.3M $79.1M -$1.11 -$1.11 $0.00
08/03/2023 Q2 -- $77.2M -$1.78 -- --
05/04/2023 Q1 -- $65.2M -$1.17 -- --
02/23/2023 Q4 -- $59.3M -$1.21 -- --
10/27/2022 Q3 -- $67.7M -$1.09 -- --
08/04/2022 Q2 -- $65.2M -$0.80 -- --
05/05/2022 Q1 -- $53.1M -$0.80 -- --
02/17/2022 Q4 -- $56.1M -$0.95 -- --
10/28/2021 Q3 -- $46.8M -$0.96 -- --
08/05/2021 Q2 -- $45.4M -$1.07 -- --
05/06/2021 Q1 -- $40.2M -$0.89 -- --
02/25/2021 Q4 -- $41.4M -$1.00 -- --
10/29/2020 Q3 -- $43.6M -$0.63 -- --
08/06/2020 Q2 -- $42.5M -$0.64 -- --
04/30/2020 Q1 -- $36.9M -$0.74 -- --
02/25/2020 Q4 -- $45.7M -$0.59 -- --
10/30/2019 Q3 -- $38.9M -$0.68 -- --
08/01/2019 Q2 -- $30M -$0.81 -- --
05/07/2019 Q1 -- $21.9M -$0.96 -- --
02/22/2019 Q4 -- $9.8M -$1.19 -- --
10/30/2018 Q3 -- -- -$1.14 -- --
08/02/2018 Q2 -- -- -$1.00 -- --
05/02/2018 Q1 -- -- -$0.89 -- --
02/23/2018 Q4 -- -- -$0.85 -- --
11/02/2017 Q3 -- -- -$0.69 -- --
08/03/2017 Q2 -- -- -$0.72 -- --
05/03/2017 Q1 -- -- -$0.60 -- --
02/23/2017 Q4 -- -- -$1.10 -- --
11/03/2016 Q3 -- -- -$0.61 -- --
08/04/2016 Q2 -- -- -$0.59 -- --
05/05/2016 Q1 -- -- -$0.54 -- --
02/26/2016 Q4 -- -- -$0.51 -- --

Insmed, Inc. Earnings Questions

  • How Much did Insmed, Inc. Generate in Revenue Last Quarter?

    Insmed, Inc. reported $142.3M worth of top line sales in its most recent quarter.

  • Did Insmed, Inc. Beat Earnings Last Quarter?

    Insmed, Inc. announced earnings per share of -$1.75 which represents a miss of analyst forecast a -$1.37 per share.

  • Is Insmed, Inc. Profitable?

    Insmed, Inc. reported $111.4M that represents $0.53 per share over the last quarter.

  • What is the Analyst Consensus for Insmed, Inc. EPS Next Year?

    Insmed, Inc.'s earnings are forecast to decrease from -$5.57 per share to -$5.34 per share next year representing a decrease of -9.72%.

  • When is Insmed, Inc.'s Earnings Date?

    Insmed, Inc.'s next earnings date is February 19, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
56
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock